NIH-funded research R21 grant

Predicting which HIV patients may stop attending care

Official title: Clinical Phenotyping for Prediction of Retention in HIV Care

Funded at University of Chicago · NIH-10762595 · Data updated 2026-11-12

This study is looking at ways to help people with HIV stay connected to their healthcare by figuring out who might need extra support to keep coming back for their appointments.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 5, 2023
Project endSeptember 4, 2025
Funding year2023
Award (this year)$452,376
NIH project number1R21MH134756-01
Project IDNIH-10762595 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who are currently receiving care but may be at risk of losing follow-up.

Less likely to help

Patients who are not currently engaged in HIV care or those who are not at risk of losing follow-up may not benefit from this research.

What this research studies

This research focuses on improving the retention of patients in HIV care by developing a predictive model that identifies individuals at risk of losing follow-up. By analyzing electronic health data and using natural language processing on provider notes, the study aims to quantify a patient's risk of disengagement from care based on their unique characteristics. The goal is to assist healthcare teams in targeting resources effectively before patients fall out of care, ultimately enhancing treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved retention rates in HIV care, helping patients maintain their treatment and health.

How similar studies have gone: Preliminary data from similar approaches using machine learning and natural language processing have shown promise in predicting patient retention in care.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Ridgway, Jessica — University of Chicago
  • Study coordinator: Ridgway, Jessica

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.